{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T06:42:38Z","timestamp":1775630558944,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R42NS120548"],"award-info":[{"award-number":["R42NS120548"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R42NS120548"],"award-info":[{"award-number":["R42NS120548"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R42NS120548"],"award-info":[{"award-number":["R42NS120548"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R42NS120548"],"award-info":[{"award-number":["R42NS120548"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"DOI":"10.1007\/s12031-025-02326-7","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T08:01:57Z","timestamp":1741939317000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effect of Fatty Acyl Composition for Lysophosphatidylinositol on Neuroinflammatory Responses in Primary Neuronal Cultures"],"prefix":"10.1007","volume":"75","author":[{"given":"Douglas E.","family":"Brenneman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Petkanas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Ippolito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara Jane","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"key":"2326_CR1","doi-asserted-by":"publisher","first-page":"11665","DOI":"10.3390\/ijms222111665","volume":"22","author":"M Apweiler","year":"2021","unstructured":"Apweiler M, Saliba SW, Streyczek J, Hurrle T et al (2021) Targeting oxidative stress: novel coumarin-based inverse agonist of GPR55. Int J Mol Sci 22:11665. https:\/\/doi.org\/10.3390\/ijms222111665","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2326_CR2","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1038\/s41380-024-02614-5","volume":"25","author":"M Apweiler","year":"2024","unstructured":"Apweiler M, Saliba SW, Sun L, Streyczek J, Normann C, Hellwig S, Brase S, Fiebich BL (2024) Modulation of neuroinflammation and oxidative stress by targeting GPR55 \u2013 new approaches in the treatment of psychiatric disorders. Mol Psych 25(12):3779\u20133788. https:\/\/doi.org\/10.1038\/s41380-024-02614-5","journal-title":"Mol Psych"},{"key":"2326_CR3","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","volume":"12","author":"CI Bih","year":"2015","unstructured":"Bih CI, Chen T, Nunn AVW, Bazelot M, Dallas M, Whalley BJ (2015) Molecular targets of cannabidiol in neurological disorders. Neurotherap 12:699\u2013730. https:\/\/doi.org\/10.1007\/s13311-015-0377-3","journal-title":"Neurotherap"},{"key":"2326_CR4","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1021\/acsmedchemlett.8b00333\/+","volume":"10","author":"M Badolato","year":"2019","unstructured":"Badolato M, Carullo G, Caroleo MC, Cione E, Aiello F, Manetti F (2019) Discovery of 1,4-naphthoquinones as a new class of antiproliferative agents targeting GPR55. ACS Med Chem Lett 10:402\u2013406. https:\/\/doi.org\/10.1021\/acsmedchemlett.8b00333\/+","journal-title":"ACS Med Chem Lett"},{"key":"2326_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s12031-018-1154-7","volume":"66","author":"DE Brenneman","year":"2018","unstructured":"Brenneman DE, Petkanas D, Kinney, (2018) Pharmacological comparisons between cannabidiol and KLS-13019. J Mol Neurosci 66:121\u2013134. https:\/\/doi.org\/10.1007\/s12031-018-1154-7","journal-title":"J Mol Neurosci"},{"key":"2326_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s12031-019-01321-z","volume":"68","author":"DE Brenneman","year":"2019","unstructured":"Brenneman DE, Kinney WA, Ward SJ (2019) Knockdown siRNA targeting the mitochondrial sodium-channel WA exchanger-1 inhibits the protective effects of two cannabinoids against acute paclitaxel toxicity. J Mol Neurosci 68:603\u2013619. https:\/\/doi.org\/10.1007\/s12031-019-01321-z","journal-title":"J Mol Neurosci"},{"key":"2326_CR7","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s12031-022-02038-2","volume":"72","author":"DE Brenneman","year":"2022","unstructured":"Brenneman DE, Kinney WA, McDonnell ME, Zhao P, Abood ME, Ward SJ (2022) Anti-inflammatory properties of KLS-13019: a novel GPR55 antagonist for dorsal root ganglion and hippocampal cultures. J Mol Neurosci 72:1859\u20131874. https:\/\/doi.org\/10.1007\/s12031-022-02038-2","journal-title":"J Mol Neurosci"},{"key":"2326_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12031-024-02217-3","volume":"74","author":"DE Brenneman","year":"2024","unstructured":"Brenneman DE, Kinney WA, McDonnell ME, Ippolito MJ, Ward SJ (2024) Knockdown of siRNA targeting GPR55 reveals significant differences between the anti-inflammatory actions of KLS-13019 and cannabidiol. J Mol Neurosci 74:41\u2013xx. https:\/\/doi.org\/10.1007\/s12031-024-02217-3","journal-title":"J Mol Neurosci"},{"key":"2326_CR9","doi-asserted-by":"publisher","first-page":"158891","DOI":"10.1016\/j.bbalip.2021.158891","volume":"1866","author":"A Caddeo","year":"2021","unstructured":"Caddeo A, Hedfalk K, Romeo S, Pingitore P (2021) LPIAT1\/MBOAT7 contains a catalytic dyad transferring polyunsaturated fatty acids to lysophosphatidylinositol. Biochim Biophys Act-Mol Cell Biol Lipids 1866:158891. https:\/\/doi.org\/10.1016\/j.bbalip.2021.158891","journal-title":"Biochim Biophys Act-Mol Cell Biol Lipids"},{"key":"2326_CR10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3892\/mmr.2022.12671","volume":"25","author":"R Chen","year":"2022","unstructured":"Chen R, Xu H, Guo Z, Zhang P, Chen J, Chen Z (2022) CID16020046, a GPR55 antagonist, attenuates sepsis-induced acute kidney injury. Mol Med Reports 25:152. https:\/\/doi.org\/10.3892\/mmr.2022.12671","journal-title":"Mol Med Reports"},{"key":"2326_CR11","doi-asserted-by":"publisher","first-page":"4516","DOI":"10.1073\/pnas.74.10.4516","volume":"10","author":"RB Campenot","year":"1977","unstructured":"Campenot RB (1977) Local control of neurite development by nerve growth factor. Proc Natl Acad Sci USA 10:4516\u20134519","journal-title":"Proc Natl Acad Sci USA"},{"key":"2326_CR12","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1111\/bph.15486","volume":"178","author":"JD Foss","year":"2021","unstructured":"Foss JD, Farkas DJ, Huynh LM, Kinney WA, Brenneman DE, Ward SJ (2021) Behavioral and pharmacological effects of cannabidiol (CBD) and the CBD analogue KLS-13019 in mouse models of pain and reinforcement. Brit J Pharmacol 178:3067\u20133078. https:\/\/doi.org\/10.1111\/bph.15486","journal-title":"Brit J Pharmacol"},{"key":"2326_CR13","doi-asserted-by":"publisher","unstructured":"Fumagalli G, Monza L, Cavaletti G, Rigolio R, Meregalli C (2021) Neuroinflammatory process involved in different preclinical models of chemotherapy-induced peripheral neuropathy. Frontiers in Immunol https:\/\/doi.org\/10.3389\/fimmu.2020.626687","DOI":"10.3389\/fimmu.2020.626687"},{"key":"2326_CR14","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/294477a0","volume":"294","author":"I Gozes","year":"1981","unstructured":"Gozes I, Sweadner KJ (1981) Multiple tubulin forms are expressed by a single neurone. Nature 294:477\u2013480","journal-title":"Nature"},{"key":"2326_CR15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/gtc.12046","volume":"18","author":"Y Hirata","year":"2024","unstructured":"Hirata Y, Yamamori N, Kono N, Hyeon-Cheol-Cheoi L, Inoue T, Arai H (2024) Identification of small subunit of serine palmitoyltransferase a as a lysophophatidylinositol acyltransferase 1-interacting protein. Genes Cells 18:397\u2013409. https:\/\/doi.org\/10.1111\/gtc.12046","journal-title":"Genes Cells"},{"key":"2326_CR16","doi-asserted-by":"publisher","unstructured":"Honkisz-Orzechowska E, Lazewska D, Baran G, Kiec-Kononowicz K (2024) Uncovering the power of GPR55 signalling: how RvD2 and other ligands have the potential to modulate and resolve inflammation in various health disorders. Molecules 29:1258. https:\/\/doi.org\/10.3390\/molecules29061258","DOI":"10.3390\/molecules29061258"},{"key":"2326_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1404441","author":"H Huang","year":"2024","unstructured":"Huang H, Li G, He Y, Chen J, Yan J, Zhang Q, Li L, Cai X (2024) Cellular succinate metabolism and signaling in inflammation: therapeutic intervention. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2024.1404441","journal-title":"Front Immunol"},{"key":"2326_CR18","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/hipo.22747","volume":"27","author":"K Hurst","year":"2017","unstructured":"Hurst K, Badgley C, Ellsworth T, Bell S, Friend L, Prince B, Welch J, Cowan Z, Williamson R (2017) A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity. Hippocampus 27:985\u2013998. https:\/\/doi.org\/10.1002\/hipo.22747","journal-title":"Hippocampus"},{"key":"2326_CR19","volume-title":"KLS-13019, a novel structural analogue of cannabidiol (CBD) and GPR55 antagonist, prevents and reverses chemotherapy-induced peripheral neuropathy (CIPN) in rats","author":"MJ Ippolito","year":"2024","unstructured":"Ippolito MJ, Kinney W, Brenneman DE, Ward SJ (2024) KLS-13019, a novel structural analogue of cannabidiol (CBD) and GPR55 antagonist, prevents and reverses chemotherapy-induced peripheral neuropathy (CIPN) in rats. In press, J Pharmacol Exp Therap"},{"key":"2326_CR20","doi-asserted-by":"publisher","unstructured":"Irving A, Abdulrazzaq G, Chan SLF, Penman J, Harvey J, Alexander SPH (2017) Cannabinoid receptor-related orphan G protein-coupled receptors. Adv Pharmacol 80:223-247. https:\/\/doi.org\/10.1016\/bs.apha.2017.04.004","DOI":"10.1016\/bs.apha.2017.04.004"},{"key":"2326_CR21","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1139\/cjpp-2018-0741","volume":"10","author":"K Iuchi","year":"2019","unstructured":"Iuchi K, Nishimaki K, Kamimura N, Ohta S (2019) Molecular hydrogen suppresses free-radical-induced cell death by mitigating fatty acid peroxidation and mitochondrial dysfunction. Can J Physiol Pharmacol 10:999\u20131005","journal-title":"Can J Physiol Pharmacol"},{"key":"2326_CR22","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1016\/S0021-9258(20)82209-1","volume":"239","author":"RW Keenan","year":"1964","unstructured":"Keenan RW, Hokin LE (1964) The enzymatic acylation of lysophosphatidylinositol. J Biol Chem 239:2123\u20132129","journal-title":"J Biol Chem"},{"key":"2326_CR23","doi-asserted-by":"publisher","first-page":"8718","DOI":"10.1038\/s41598-022-12293-3","volume":"12","author":"N Kondo","year":"2022","unstructured":"Kondo N, Sakurai Y, Takata T, Kano K, Kume K, Maeda M, Takai N, Suzuki S, Eto F et al (2022) Persistent elevation of lysophosphatidylcholine promotes radiation brain necrosis with microglial recruitment by P2RX4. Sci Reports 12:8718. https:\/\/doi.org\/10.1038\/s41598-022-12293-3","journal-title":"Sci Reports"},{"key":"2326_CR24","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.10091\/mbc.E12-09-0673","volume":"23","author":"HC Lee","year":"2012","unstructured":"Lee HC, Inoue T, Sasaki J, Kubo T, Matsuda S, Nakasaki Y, Hattore M et al (2012) LPIAT1 regulates arachidonic acid content in phosphatidylinositol and is required for cortical lamination in mice. Mol Biol Cell 23:4689. https:\/\/doi.org\/10.1091\/mbc.E12-09-0673","journal-title":"Mol Biol Cell"},{"key":"2326_CR25","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1021\/acs.biochem.6b01013","volume":"56","author":"MA Lingerfelt","year":"2017","unstructured":"Lingerfelt MA, Zhao P, Sharir H, Hurst DP, Reggio PH, Abood ME (2017) Identification of crucial amino acid residues involved in agonist signaling at the GPR55 receptor. Biochemistry 56:473\u2013486. https:\/\/doi.org\/10.1021\/acs.biochem.6b01013","journal-title":"Biochemistry"},{"key":"2326_CR26","doi-asserted-by":"publisher","first-page":"771","DOI":"10.2174\/1570159X14666160729155441","volume":"15","author":"B Marichal-Cancino","year":"2017","unstructured":"Marichal-Cancino B, Fajardo-Valdez AE, Ruiz-Contreras A, Mendez-Diaz M, Prospero-Garcia O (2017) Advances in the physiology of GPR55 in the central nervous system. Curr Neuropharm 15:771\u2013778. https:\/\/doi.org\/10.2174\/1570159X14666160729155441","journal-title":"Curr Neuropharm"},{"key":"2326_CR27","doi-asserted-by":"publisher","first-page":"6316","DOI":"10.3390\/ijms24076316","volume":"24","author":"LM Martinez-Aguilar","year":"2023","unstructured":"Martinez-Aguilar LM, Ibarra-Sanchez A, Guerrero-Morian DJ, Macias-Silva M, Munoz-Billo JO et al (2023) Lysophosphatidylinositol promotes chemotaxis and cytokine synthesis in mast cells with differential participation of GPR55 and CB2 receptors. I J Mol Sci 24:6316. https:\/\/doi.org\/10.3390\/ijms24076316","journal-title":"I J Mol Sci"},{"key":"2326_CR28","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.bbalip.2018.09.003","volume":"1863","author":"J Masquelier","year":"2018","unstructured":"Masquelier J, Alhouayek M, Terrasi R, Bottemanne P, Paquot A, Muccioli G (2018) Lysophosphatidylinositols in inflammation and macrophage activation: altered levels and anti-inflammation effects. Biochim Biophys Acta Mol Cell Biol Lipids 1863:1458\u20131468. https:\/\/doi.org\/10.1016\/j.bbalip.2018.09.003","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"2326_CR29","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3390\/biology12060805","volume":"12","author":"D Medina-Vera","year":"2023","unstructured":"Medina-Vera D, Zhao H, Bereczki E, Rosell-Valle C, Shimozawa M, Chen G, Rodriguez de Fonseca F, Nilsson P, Tambaro S (2023) The expression of the endocannabinoid receptors CB2 and GPR55 is highly increased during the progression of Alzheimer\u2019s disease in APPNL-G-F knock-in mice. Biol 12:805. https:\/\/doi.org\/10.3390\/biology12060805","journal-title":"Biology (Basel)"},{"key":"2326_CR30","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s10753-020-01271-4","volume":"43","author":"T Minamihata","year":"2020","unstructured":"Minamihata T, Takano K, Moriyama M, Nakamura Y (2020) Lysophosphatidylinositol, an endogenous ligand for G protein-coupled receptor 55, has anti-inflammatory effects in cultured microglia. Inflammation 43:1971\u20131987. https:\/\/doi.org\/10.1007\/s10753-020-01271-4","journal-title":"Inflammation"},{"key":"2326_CR31","doi-asserted-by":"publisher","unstructured":"Miranda AM, Bravo FV, Chan RB, Sousa N, Di Paolo G, Oliveira TG (2019) Differential lipid composition and regulation along the hippocampal longitudinal axis. Trans Psych. https:\/\/doi.org\/10.1038\/s41398-019-0478-6","DOI":"10.1038\/s41398-019-0478-6"},{"key":"2326_CR32","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1084\/jem.20110367","volume":"208","author":"E Naik","year":"2011","unstructured":"Naik E, Dixit VM (2011) Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J Exp Med 208:417\u2013420. https:\/\/doi.org\/10.1084\/jem.20110367","journal-title":"J Exp Med"},{"key":"2326_CR33","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/brain\/awz063","volume":"142","author":"RY North","year":"2019","unstructured":"North RY, Li Y, Ray P, Rhines LD, Tatsui CE, Rao G, Johansson CA, Zhang H, Kim YH et al (2019) Electrophysiological and transcriptomic correlates of neuropathic pain in human dorsal root ganglion neurons. Brain 142:1215\u20131226. https:\/\/doi.org\/10.1093\/brain\/awz063","journal-title":"Brain"},{"key":"2326_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/jb\/mvn136","volume":"145","author":"S Oka","year":"2009","unstructured":"Oka S, Toshida T, Maruyama K, Nakajima K, Yamashita A, Sugiura T (2009) 2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand of GPR55. J Biochem 145:13\u201320","journal-title":"J Biochem"},{"key":"2326_CR35","doi-asserted-by":"publisher","first-page":"e24284","DOI":"10.1371\/jornal.pone.0024284","volume":"6","author":"Y Obara","year":"2011","unstructured":"Obara Y, Ueno S, Yanagihata Y, Nakahata N (2011) Lysophosphatidylinositol causes neurite retraction via GPR55, G13 and RhoA in PC12 cells. PLoS ONE 6:e24284. https:\/\/doi.org\/10.1371\/jornal.pone.0024284","journal-title":"PLoS ONE"},{"key":"2326_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuroscience.2020.07.013","volume":"443","author":"BN Okine","year":"2020","unstructured":"Okine BN, Mc Laughlin G, Gaspar JC, Harhen B, Roche M, Finn DP (2020) Antinociceptive effects on the GPR55 antagonists CID16020046 injected into the rat anterior cingulate cortex. Neurosci 443:19\u201329. https:\/\/doi.org\/10.1016\/j.neuroscience.2020.07.013","journal-title":"Neurosci"},{"key":"2326_CR37","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3390\/cells9071687","volume":"9","author":"M Pajares","year":"2020","unstructured":"Pajares M, Rojo A, Manda G, Bosco L, Cuadrado A (2020) Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications. Cells 9:1687. https:\/\/doi.org\/10.3390\/cells9071687","journal-title":"Cells"},{"key":"2326_CR38","doi-asserted-by":"publisher","first-page":"105822","DOI":"10.1016\/j.phrs.2021.105822","volume":"172","author":"S Paternoster","year":"2021","unstructured":"Paternoster S, Simpson PV, Kokh E, Kizilkaya HS, Rosenkilde MM, Mancera RL, Keating DJ, Massimiliano M, Falasca M (2021) Pharmacological and structure-activity relationship studies of oleoyl-lysophosphatidylinositol synthetic mimetics. Pharm Res 172:105822. https:\/\/doi.org\/10.1016\/j.phrs.2021.105822","journal-title":"Pharm Res"},{"key":"2326_CR39","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/j.febslet.2009.05.028","volume":"583","author":"M Pietr","year":"2009","unstructured":"Pietr M, Kozela E, Levy R, Rimmerman N, Lin YH, Stella N, Vogel Z, Juknat A (2009) Differential changes in GPR55 during microglial cell activation. FEBS Lett 583:2071\u20132076. https:\/\/doi.org\/10.1016\/j.febslet.2009.05.028","journal-title":"FEBS Lett"},{"key":"2326_CR40","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1507\/endocrj.EJ16-0084","volume":"63","author":"J Sato","year":"2016","unstructured":"Sato J, Makit N, Iiri T (2016) Inverse agonism: the classic concept of GPCRs revisited. Endocrine J 63:507\u2013514. https:\/\/doi.org\/10.1507\/endocrj.EJ16-0084","journal-title":"Endocrine J"},{"key":"2326_CR41","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12974-018-1362-7","volume":"15","author":"SW Saliba","year":"2018","unstructured":"Saliba SW, Jauch H, Gargouri B, Keil A, Hurrle T, Volz N, Mohr F, van der Stelt M, Brase S, Fiebich BL (2018) Anti-neuroinflammatory effect of GPR55 antagonists in LPS-activated primary microglial cells. J Neuroinflam 15:322. https:\/\/doi.org\/10.1186\/s12974-018-1362-7","journal-title":"J Neuroinflam"},{"key":"2326_CR42","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.pharmthera.2010.02.004","volume":"126","author":"H Sharir","year":"2010","unstructured":"Sharir H, Abood ME (2010) Pharmacological characterization of GPR55, a putative cannabinoid receptor. Pharmacol Ther 126:301\u2013313. https:\/\/doi.org\/10.1016\/j.pharmthera.2010.02.004","journal-title":"Pharmacol Ther"},{"key":"2326_CR43","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/pain.2008.04.006","volume":"139","author":"PC Staton","year":"2008","unstructured":"Staton PC, Hatcher JP, Walker DJ, Morrison AD, Shapland EN, Hughes JP, Chong E, Mander PK et al (2008) The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain. Pain 139:225\u2013236. https:\/\/doi.org\/10.1016\/pain.2008.04.006","journal-title":"Pain"},{"key":"2326_CR44","doi-asserted-by":"crossref","unstructured":"SuofuY, Li W, Jean-Alphonse FG, Jia J, Khattar NK Li J et al (2017) Dual role of mitochondria in producing melatonin and driving GPRC signaling to block cytochrome c release. PNAS 114(38): E7997-E8006. www.pnas.org\/cgi\/doi\/10.1073\/pnas.1705768114S","DOI":"10.1073\/pnas.1705768114"},{"key":"2326_CR45","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/ejn.14720","volume":"53","author":"R Troubat","year":"2021","unstructured":"Troubat R, Barone P, Leman S, Desmidt T, Cressant A, Atanasova B, Brizard B, El Hage W, Surget A, Belzung C, Camus V (2021) Neuroinflammation and depression: a review. Eur J Neurosci 53:151\u2013171. https:\/\/doi.org\/10.1111\/ejn.14720","journal-title":"Eur J Neurosci"},{"key":"2326_CR46","doi-asserted-by":"publisher","first-page":"872760","DOI":"10.3389\/fimmu2022.872760","volume":"13","author":"E Valdez-Morales","year":"2022","unstructured":"Valdez-Morales E, Sanchez-Navarro C, Reyes-Pavon D, Barrios-Garcia T, Ochoa-Cortes F, Barajas-Espinosa, et al (2022) TNF-\u03b1 enhances sensory DRG neuron excitability through modulation of P2X3 receptors in an acute colitis model. Front Immunol 13:872760. https:\/\/doi.org\/10.3389\/fimmu2022.872760","journal-title":"Front Immunol"},{"key":"2326_CR47","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1126\/science.288.5472.1765","volume":"288","author":"CJ Woolf","year":"2000","unstructured":"Woolf CJ, Salter MW (2000) Neuronal plasticity: increasing the gain in pain. Science 288:1765\u20131769. https:\/\/doi.org\/10.1126\/science.288.5472.1765","journal-title":"Science"},{"key":"2326_CR48","doi-asserted-by":"publisher","first-page":"13328","DOI":"10.3390\/ijms222413328","volume":"22","author":"A Wnorowski","year":"2021","unstructured":"Wnorowski A, Wojcik J, Maj M (2021) Gene expression data mining reveals the involvement of GPR55 and its endogenous ligands in immune response, cancer, and differentiation. Intl J Mol Sci 22:13328. https:\/\/doi.org\/10.3390\/ijms222413328","journal-title":"Intl J Mol Sci"},{"key":"2326_CR49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.prostaglandins.2013.05.004","volume":"107","author":"A Yamashita","year":"2013","unstructured":"Yamashita A, Oka S, Tanikawa T, Hayashi Y, Nemoto-Sasaki Y, Suigiura T (2013) The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55. Prostaglandins Other Lipid Mediat 107:103\u2013116. https:\/\/doi.org\/10.1016\/j.prostaglandins.2013.05.004","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"2326_CR50","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3389\/fphar.2016.00264","volume":"7","author":"J Zhou","year":"2016","unstructured":"Zhou J, Burkovskiy I, Yang H, Sardinha J, Lehmann C (2016) CB2 and GPP55 receptors as therapeutic targets for systemic immune dysregulation. Front Pharmacol. 7:264. https:\/\/doi.org\/10.3389\/fphar.2016.00264","journal-title":"Front Pharmacol."},{"key":"2326_CR51","doi-asserted-by":"publisher","unstructured":"Zuniga-Romero A, Rivera-Plata Q, Arrieta J, Flores-Murrieta FJ, Rodriguez-Silverio J, Reyes-Garcia JG, Huerta-Cruz JC, Ramirez-Martinez G, Rocha-Gonzalez HI (2024) GPR55 and GPR119 contribute to the processing of neuropathic pain in rats. Pharmaceuticals (Basel) 15:67. https:\/\/doi.org\/10.3390\/ph15010067\u00a0","DOI":"10.3390\/ph15010067"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-025-02326-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-025-02326-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-025-02326-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T11:01:28Z","timestamp":1743678088000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-025-02326-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["2326"],"URL":"https:\/\/doi.org\/10.1007\/s12031-025-02326-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5742954\/v1","asserted-by":"object"}]},"ISSN":["1559-1166"],"issn-type":[{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]},"assertion":[{"value":"31 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research did not involve animal or human subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Dr. Brenneman is a patent holder of KLS-13019, an antagonist to the GPR55 receptor which is mentioned in this paper. Dr. Brenneman in on the editorial board of the Journal of Molecular Neuroscience.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"35"}}